Lineage Cell Therapeutics Inc. — Investor Relations & Filings
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel allogeneic cell therapies for unmet medical needs. The company's proprietary platform uses directed differentiation of pluripotent stem cells to manufacture specialized human cells. These "off-the-shelf" cell transplants are designed to replace or support dysfunctional cells in patients with serious conditions, aiming to restore or enhance physiological function. The therapeutic pipeline is focused on degenerative diseases of the eye, such as dry age-related macular degeneration, and neurological conditions, including spinal cord injury. The company leverages its integrated capabilities in cell line development, manufacturing, and delivery to advance its programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K | 2026-03-05 | English | |
| 8-K | 2026-03-05 | English | |
| To Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 | 2026-02-26 | English | |
| To Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 | 2026-02-26 | English | |
| 4 Filing | 2026-02-13 | English | |
| 4 Filing | 2026-02-13 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 46147741 | 10-K | 2026-03-05 | English | ||
| 46147761 | 8-K | 2026-03-05 | English | ||
| 32847200 | To Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 | 2026-02-26 | English | ||
| 32847199 | To Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 | 2026-02-26 | English | ||
| 24647138 | 4 Filing | 2026-02-13 | English | ||
| 24647019 | 4 Filing | 2026-02-13 | English | ||
| 12184097 | Lineage Cell Therapeutics Issues Letter to Stockholders | 2026-01-06 | English | ||
| 12184095 | Lineage Cell Therapeutics Issues Letter to Stockholders | 2026-01-06 | English | ||
|
2025
7 filings
| |||||
| 24647433 | 4 Filing | 2025-12-19 | English | ||
| 24647355 | 4 Filing | 2025-12-19 | English | ||
| 9843950 | 8-K | 2025-11-28 | English | ||
| 9843951 | 8-K | 2025-11-24 | English | ||
| 9843958 | Major Shareholding Notification 2025 | 2025-11-15 | English | ||
| 9843952 | 8-K | 2025-11-12 | English | ||
| 9843964 | 424B3 | 2025-11-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Lineage Cell Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/6895/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=6895 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=6895 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=6895 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 6895}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lineage Cell Therapeutics Inc. (id: 6895)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.